drugset / Trial / NCT05084222
Use of Buventol Easyhaler and Bufomix Easyhaler in Methacoline Challenge Testing
RandomizedParallel-groupOpen-labelTreatment
Summary
The study compares Buventol® Easyhaler® and Bufomix® Easyhaler® to the current standard treatment during methacholine challenge test. The trial will also provide inspiratory flow profile data for Easyhaler inhaler. This trial is designed to provide a further evidence for the use of Easyhaler in diagnostic bronchial challenge tests and on the use of Easyhaler inhaler during obstructive event.
Timeline
- Start
- 2021-11-11
- Primary completion
- 2023-06-30
- Completion
- 2023-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Budesonide | Small molecule | 320 ug | Inhaled |
| Subject | Formoterol | Other / unclassified | 9 ug | Inhaled |
| Subject | Salbutamol | Unknown | 100 ug | Inhaled |
| Subject | Salbutamol | Unknown | 200 ug | Inhaled |